Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Ribometrix received early financing of $7.5M on 2017-10-31.
| Series | Round size | Date |
|---|---|---|
| Seed | $7.5M | 10/2017 |
| Series A | $30M | 11/2018 |
| Series Unknown | $7.8M | 09/2019 |
| Investors | Security type |
|---|---|
| Hatteras Venture Partners | Seed |
| MP Healthcare Venture Management | Seed |
| SV Health Investors LLC | Seed |
| AbbVie Biotech Ventures Inc | Seed |
| Dementia Discovery Fund | Seed |
| Alexandria Venture Investments | Seed |
| Illumina Ventures | Series A |
| Hatteras Venture Partners | Series A |
| M Ventures | Series A |
| Pappas Ventures | Series A |
| MP Healthcare Venture Management | Series A |
| SV Health Investors LLC | Series A |
| Amgen | Series A |
| AbbVie Biotech Ventures Inc | Series A |
| Dementia Discovery Fund | Series A |
| Alexandria Venture Investments | Series A |
| Illumina Ventures | Series Unknown |
| MP Healthcare Venture Management | Series Unknown |
| Dementia Discovery Fund | Series Unknown |
Ribometrix's top competitor, Frequency Therapeutics, earned an annual revenue of $2.3M.
Ribometrix's smallest competitor is Cylene Pharmaceuticals with revenue of $284.9K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Arrakis Therapeutics | - | $1.0M | 78 | - |
| Skyhawk Therapeutics | - | $580,000 | 30 | - |
| Frequency Therapeutics | - | $2.3M | 83 | - |
| Expansion Therapeutics | - | $590,000 | 35 | - |
| Cylene Pharmaceuticals | - | $284.9K | 3 | - |
| VIA Pharmaceuticals, Inc. | - | $940,000 | 5 | - |
Zippia gives an in-depth look into the details of Ribometrix, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Ribometrix. The employee data is based on information from people who have self-reported their past or current employments at Ribometrix. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Ribometrix. The data presented on this page does not represent the view of Ribometrix and its employees or that of Zippia.
Ribometrix may also be known as or be related to Ribometrix, Ribometrix Inc and Ribometrix, Inc.